Electromotive Drug Administration (EMDA) is a medical procedure that uses electrical current to enhance the delivery of therapeutic drugs or substances into the body. It is a specialized technique that facilitates the transdermal administration of drugs, bypassing the traditional oral or injection routes.
EMDA involves the application of low-level electrical current to the skin, which creates temporary pathways or channels known as “pores” in the skin's outer layer, called the stratum corneum. These pores allow for enhanced drug absorption by improving the permeability of the skin. By harnessing the power of electrical currents, the drugs can effectively penetrate the skin and reach the underlying layers, enhancing their therapeutic effects.
The electrical current used in EMDA is typically low in intensity and applied through the use of specific electrodes or devices. The level of current is carefully controlled to ensure patient safety and optimal drug delivery. Additionally, the drugs used in EMDA are specifically formulated to be compatible with this delivery method, allowing for efficient absorption.
EMDA has been found to be particularly effective for the administration of certain medications, such as local anesthetics, anti-inflammatory drugs, and drugs used in tumor treatment. The procedure is non-invasive and typically well-tolerated by patients, making it a potential alternative to other drug delivery methods that can cause discomfort or adverse side effects.
In summary, Electromotive Drug Administration is a medical procedure that uses controlled electrical currents to enhance the delivery of therapeutic drugs into the body through the skin. This method offers a non-invasive alternative for drug administration and has shown promising results in the efficient absorption of certain medications.
